Organoids thread

View Christine Ho, Ph.D’s profile

Christine Ho, Ph.D

• 2nd

Lead Biologist @OWLO | Preclinical R&D | Organoid & 3D Model Expert | Bridging Organoids & IVF Technologies | Life Sciences Consultant | Co-Founder editor & Bioventure Ninja @Bench2Ventures

9h •

Connect

5 protocols. All generate “cardiac-like aggregates”. All express a Cardiac cell marker (cTnT). :white_check_mark:
But look at them. :eyes:

Same stem cell line. Same differentiation goal. Same final markers.

Five completely different morphologies. Five completely different trajectories. Five completely different Pokémon. :video_game:

:clipboard: Protocol 1 → Compact. Dense. Gengar energy.
:purple_circle: Protocol 2 → Shapeshifting blob. Pure Ditto.
:black_circle: Protocol 3 → Round then chaotic. Classic Gastly.
:purple_heart: Protocol 4 → Aggressive expansion. Haunter vibes.
:brown_circle: Protocol 5 → Dense. Dark. Shapeless. Muk energy.

All cardiac marker positive at day 10. :white_check_mark:
All “cardiac-like aggregates” by the paper definition. :white_check_mark:

:warning: But are they the same model?

Same markers ≠ same biology.
Same markers ≠ same drug response.
Same markers ≠ reproducible science.

This is why “organoids” tells you almost nothing without knowing which protocol, which morphology, which functional readout.

The field has 20+ published protocols. They all work. They all give you cTnT+ cells. But they don’t give you the same organoid. :microscope:

:koala: Koala reviewed all 5 protocols. He has a favorite. He won’t tell you which one.
Which protocol would YOU trust for drug screening? :down_arrow:

#Organoids #StemCells #Reproducibility #DrugDiscovery #NAMs #Preclinical

View image

92 reactions92

6 comments6 comments

5 reposts5 reposts


Like

Comment

Repost

Send

Anichavezhi Devendran 2ndAnichavezhi Devendran • 2nd

Scientist, Stem Cell Therapies, Regenerative Medicine, Cardiovascular Science, Genetics and Genomics, Neurodevelopmental delays,STEM, Science Communicator

8h

Follow

Spot On! and yes, this is why I love open-science discussions.